The University of Kansas Cancer Center 2020 ASCO Highlights

https://www.kucancercenter.org/

 

The University of Kansas Cancer Center 2020 ASCO Highlights
J

2020 ASCO NSCLC Highlights: Can We Consider Nivo + Ipi a Novel Chemo-Sparing 1L Option for Advanced Disease? How Effective is Tiragolumab Addition to Atezo in 1L PD-L1 Disease?

By The University of Kansas Cancer Center 2020 ASCO Highlights FEATURING Jun Zhang
By The University of Kansas Cancer Center 2020 ASCO Highlights FEATURING Jun Zhang
142 views
September 9, 2020
Comments 0
Login to view comments. Click here to Login

Featured Video

08:44
Johnson & Johnson

Management and Proactive Care of Adverse Events Associated with Loca…

Feat. J. Sabari, A. Spira

Featured Video

23:14
AstraZeneca Oncology

Management Strategies for Nausea and Vomiting in First-line Maintena…

Feat. D. Czel, C. Arn
Videos
10:04

2020 ASCO Update on ES-SCLC: Does the Addition of Anti-CTLA-4 Tremel…

The University of Kansas Cancer Center 2020 ASCO Highlights

J. Zhang

228 views
13:10

2020 ASCO NSCLC Highlights: Can We Consider Nivo + Ipi a Novel Chemo…

The University of Kansas Cancer Center 2020 ASCO Highlights

J. Zhang

142 views
08:14

2020 ASCO Highlights on NSCLC Targeted Therapy: T-DXd for HER2-Mutat…

The University of Kansas Cancer Center 2020 ASCO Highlights

J. Zhang

127 views
08:28

2020 ASCO Update on mCRC: Does T-DXd Have Potential in HER2+ Disease…

The University of Kansas Cancer Center 2020 ASCO Highlights

A. Saeed

34 views
12:44

2020 ASCO Update on Rectal Cancer: Should We Consider Total Neoadjuv…

The University of Kansas Cancer Center 2020 ASCO Highlights

A. Saeed

1.6K views
11:42

2020 ASCO Update on MSI-H mCRC: Is Pembrolizumab More Beneficial Tha…

The University of Kansas Cancer Center 2020 ASCO Highlights

A. Saeed

171 views
09:40

2020 ASCO Update on Gastroesophageal Cancer: Is Cabozantinib + Durva…

The University of Kansas Cancer Center 2020 ASCO Highlights

A. Saeed

165 views
09:55

ASCO 2020 Updates on Epithelial Ovarian Cancer: How Effective Is Sec…

The University of Kansas Cancer Center 2020 ASCO Highlights

A. Jewell, C. Salyer

97 views
07:24

ASCO 2020 Updates on Cervical Cancer and GTD: Sequential Chemo vs. R…

The University of Kansas Cancer Center 2020 ASCO Highlights

A. Jewell, C. Salyer

148 views
14:55

2020 ASCO Update on Neoadjuvant Therapy in TNBC: Does Sequential AC/…

The University of Kansas Cancer Center 2020 ASCO Highlights

P. Sharma

1.4K views
06:08

2020 ASCO Update on Neoadjuvant Therapy in TNBC: How Effective Is th…

The University of Kansas Cancer Center 2020 ASCO Highlights

P. Sharma

331 views
18:35

ASCO 2020 Symptoms and Survivorship Highlights: Does Early Palliativ…

The University of Kansas Cancer Center 2020 ASCO Highlights

E. Wulff-Burchfield

17 views